Advertisement

Topics

DepoMed Company Profile

00:34 EDT 25th September 2017 | BioPortfolio

DepoMed, Inc. is a drug delivery company developing new and proprietary oral delivery technologies to improve pharmaceutical products. The company has developed two types of oral drug delivery systems: the Gastric Retention (GR) System and the Reduced Irritation (RI) System.

DepoMed’s strategy is to establish collaborations with pharmaceutical, biotechnology, and generic drug companies to develop and commercialize products utilizing the DepoMed Systems. DepoMed technology can provide pharmaceutical companies with a means of developing new and/or improved products and extending existing patent franchises. New formulations of off-patent drugs developed using DepoMed’s technology may be differentiated from existing generic products by virtue of significant improvements in drug delivery. Concurrently, the company is also developing its own line of proprietary products incorporating off-patent and over-the-counter drugs.

Location

1360 O'Brian Drive
Menlo Park
CA
94025
United States of America

Contact

Phone: 650 462 5900
Fax: (650) 462-9993
Email: TradeRelations@depomedinc.com


News Articles [37 Associated News Articles listed on BioPortfolio]

DEPOMED INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Depomed, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / September 8, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Depomed, Inc. ("Depomed" or the "Company") (NASDAQ: DEPO) of the O...

Critical Contrast: Depomed

The Medicines Company and Depomed are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recomm...

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Depomed, Inc. of Class Action Lawsuit and Upcoming Deadline - DEPO

NEW YORK, NY / ACCESSWIRE / September 5, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Depomed, Inc. ("Depomed" or the "Company") (NASDAQ: DEPO) and certain of i...

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Depomed, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 18, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (NASDAQ: DEPO) for ...

IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Depomed, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 14, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (NASDAQ: DEPO) for ...

SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Depomed, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 20, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (NASDAQ: DEPO) for ...

SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Depomed, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 1, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Depomed, Inc. ('Depomed' or the 'Company') (NASDA...

Depomed To Present At Jefferies 2013 Global Healthcare Conference

NEWARK, Calif., May 28, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt in New Y...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Gralise [Depomed, Inc.]

These highlights do not include all the information needed to use GRALISE safely and effectively. See full prescribing information for GRALISE. GRALISE™ (gabapentin) tablets Initial U.S. Approval: 1...

Proquin [Depomed, Inc.]

Proquin XR (ciprofloxacin hydrochloride) Extended-Release Tablets, 500 mg

PubMed Articles [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women

Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of Gabapentin that is being studied for the treatment of Hot Flashes/Hot Flushes in postmenopausal...

Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women.

Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women.

Companies [5 Associated Companies listed on BioPortfolio]

DepoMed

DepoMed, Inc. is a drug delivery company developing new and proprietary oral delivery technologies to improve pharmaceutical products. The company has developed two types of oral drug delivery systems...

Depomed, Inc.

Depomed, Inc. is a specialty pharmaceutical company with one product candidate through Phase 3 clinical development, another in Phase 3 clinical development, two approved products...

Santarus, Inc. and Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by phy...

Santarus, Inc. & Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by phy...

Depomed, Inc. & Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood’s GC-C agonis...

More Information about "DepoMed" on BioPortfolio

We have published hundreds of DepoMed news stories on BioPortfolio along with dozens of DepoMed Clinical Trials and PubMed Articles about DepoMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DepoMed Companies in our database. You can also find out about relevant DepoMed Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record